Scientists have discovered that specific structural changes in lymph nodes can serve as indicators for predicting the spread of breast cancer, which may lead to more personalized treatment approaches. This study, funded by Breast Cancer Now, analyzed 331 lymph node samples from patients with various breast cancer types, focusing on the fibroblastic reticular cells (FRC) that support lymph node structure and immune response. Notably, changes in the FRC network can occur even before cancer cells are detectable, and these alterations differ based on the type of breast cancer and treatment history. Dr. Simon Vincent, chief scientific officer at Breast Cancer Now, emphasized the importance of this research in identifying patients who may benefit from tailored therapies, potentially avoiding unnecessary surgeries and long-term side effects like lymphoedema. The study's findings could pave the way for new treatment targets and better patient management, addressing the urgent need for improved understanding of breast cancer progression. The research is published in the Journal of Pathology.